151 related articles for article (PubMed ID: 18671471)
1. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
Manenti L; Tansinda P; Vaglio A
Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
[TBL] [Abstract][Full Text] [Related]
2. Eprodisate for the treatment of renal disease in AA amyloidosis.
Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puéchal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
N Engl J Med; 2007 Jun; 356(23):2349-60. PubMed ID: 17554116
[TBL] [Abstract][Full Text] [Related]
3. Eprodisate in AA amyloidosis.
Manenti L; Tansinda P; Vaglio A
N Engl J Med; 2007 Sep; 357(11):1153; author reply 1153-4. PubMed ID: 17855678
[No Abstract] [Full Text] [Related]
4. [Amyloidosis in rheumatic diseases].
Zdrojewski Z
Ann Acad Med Stetin; 2010; 56 Suppl 1():7-15. PubMed ID: 21365934
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.
Hazenberg BP; Bijzet J; Limburg PC; Skinner M; Hawkins PN; Butrimiene I; Livneh A; Lesnyak O; Nasonov EL; Filipowicz-Sosnowska A; Gül A; Merlini G; Wiland P; Ozdogan H; Gorevic PD; Maïz HB; Benson MD; Direskeneli H; Kaarela K; Garceau D; Hauck W; Van Rijswijk MH
Amyloid; 2007 Jun; 14(2):133-40. PubMed ID: 17577686
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of amyloidosis.
Rajkumar SV; Gertz MA
N Engl J Med; 2007 Jun; 356(23):2413-5. PubMed ID: 17554124
[No Abstract] [Full Text] [Related]
7. Review of eprodisate for the treatment of renal disease in AA amyloidosis.
Rumjon A; Coats T; Javaid MM
Int J Nephrol Renovasc Dis; 2012; 5():37-43. PubMed ID: 22427728
[TBL] [Abstract][Full Text] [Related]
8. [A new treatment of renal disease in AA amyloidosis...and not only that?].
Pani A
G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
[No Abstract] [Full Text] [Related]
9. [Diagnostics and therapy of AA amyloidosis].
Blank N; Lorenz HM
Pathologe; 2009 May; 30(3):219-25. PubMed ID: 19333604
[TBL] [Abstract][Full Text] [Related]
10. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for amyloid A amyloidosis.
Pettersson T; Konttinen YT; Maury CP
Expert Opin Pharmacother; 2008 Aug; 9(12):2117-28. PubMed ID: 18671466
[TBL] [Abstract][Full Text] [Related]
12. Colchicine use in isolated renal AA amyloidosis.
Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
[TBL] [Abstract][Full Text] [Related]
13. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome.
Livneh A; Zemer D; Langevitz P; Laor A; Sohar E; Pras M
Arthritis Rheum; 1994 Dec; 37(12):1804-11. PubMed ID: 7986228
[TBL] [Abstract][Full Text] [Related]
14. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
15. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
[TBL] [Abstract][Full Text] [Related]
16. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine.
Korkmaz C
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S104-7. PubMed ID: 23010471
[TBL] [Abstract][Full Text] [Related]
18. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
19. [New trends in the treatment of amyloidosis].
Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
[TBL] [Abstract][Full Text] [Related]
20. [Familial Mediterranean fever with amyloidosis. Recent pathogenetic and therapeutic aspects].
Löffler HJ; Brass H; Thoenes W; Linke RP
Dtsch Med Wochenschr; 1983 Feb; 108(6):210-5. PubMed ID: 6825596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
